Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000416215 | SCV000493220 | likely pathogenic | not provided | 2016-08-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000034248 | SCV001386721 | pathogenic | Hereditary spastic paraplegia 11 | 2023-12-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile2246Serfs*15) in the SPG11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG11 are known to be pathogenic (PMID: 19105190, 20110243, 22154821, 26556829). This variant is present in population databases (rs312262781, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with hereditary spastic paraplegia (PMID: 18079167). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 41347). For these reasons, this variant has been classified as Pathogenic. |
Ai |
RCV000416215 | SCV002502658 | pathogenic | not provided | 2022-03-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000034248 | SCV002763675 | likely pathogenic | Hereditary spastic paraplegia 11 | criteria provided, single submitter | clinical testing | ||
Fulgent Genetics, |
RCV002496511 | SCV002808795 | pathogenic | Amyotrophic lateral sclerosis type 5; Hereditary spastic paraplegia 11; Charcot-Marie-Tooth disease axonal type 2X | 2021-07-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000034248 | SCV000058188 | not provided | Hereditary spastic paraplegia 11 | no assertion provided | literature only |